LACTAM-SUBSTITUIERTE PYRAZOLOPYRIDINDERIVATE
    6.
    发明授权
    LACTAM-SUBSTITUIERTE PYRAZOLOPYRIDINDERIVATE 有权
    内酰胺取代的吡唑并衍生物

    公开(公告)号:EP1339716B1

    公开(公告)日:2004-11-03

    申请号:EP01997487.2

    申请日:2001-11-09

    CPC分类号: C07D471/04

    摘要: The invention relates to novel pyrazolopyridine derivatives of formula (I) wherein R1 represents NH¿2? or NHCO-C1-6-alkyl, and R?2¿ represents a radical of formula R3NCOR4 which is bonded to the radical of the molecule by means of the nitrogen atom, R?3 and R4¿ forming, together with the amide group to which they are bonded, a five to six-membered heterocycle which can be saturated or partially unsaturated, can optionally contain another heteroatom from the group N, O, S and can comprise between one and five other substituents from the group oxo, C1-6 alkyl, hydroxy, hydroxy-C¿1-6?-alkyl, halogen, or can be anellated to a C6-10 aryl ring or a C3-8 cycloalkyl ring in which optionally two carbon atoms are bonded to each other by means of an oxygen atom. The invention also relates to salts, isomers and hydrates of said derivatives, in the form of stimulators of soluble guanylate cyclase and as agents for treating cardiovascular diseases, hypertonia, thrombo-embolic diseases and ischaemia, sexual dysfunction, inflammations, and diseases of the central nervous system.